Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 3
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Iptacopan (LNP023) in Idiopathic Immune-complex-mediated Membranoproliferative Glomerulonephritis (IC-MPGN)
This study is designed as a multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (L…
IC-MPGN
Novartis PharmaceuticalsNCT05755386
Phase 2
A Phase 2 Study to Assess ADX-038 in Participants With Complement-Mediated Kidney Disease
This Phase 2 study is designed to assess the safety, efficacy, pharmacokinetics (PK) and pharmacodynamics (PD) of ADX-038 in adults with complement-mediated ki…
IgANC3GComplement-mediated Kidney Disease+2 more
ADARx Pharmaceuticals, Inc.NCT06989359